{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:56:49Z","timestamp":1790665009804,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypercortisolism and type 2 diabetes mellitus (T2D) independently contribute to an increased burden of cardiometabolic morbidity and mortality. However, data on the interaction of hypercortisolism and T2D are scarce\u2014thus, we aimed to assess the cortisol-associated morbidity and mortality in the context of T2D and adrenal mild autonomous cortisol secretion (MACS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective cohort study including 668 patients with adrenal adenomas, who were visiting the endocrine outpatient clinic at the Vienna General Hospital between 01.01.2000 to 31.12.2022. Of those, 151 were diagnosed with T2D at the time of their 1\u00a0mg dexamethasone suppression test (DST), other diabetes types were excluded. MACS was defined as a post 1\u00a0mg DST cortisol of &gt;\u20091.8\u00a0\u00b5g\/dL in the absence of Cushing\u2019s stigmata and after biochemical exclusion of ACTH-dependency. The database was linked to the governmental death registry and patients alive after 01.12.2024 were censored. Kaplan Meier curves and cox proportional hazard models were analyzed via RStudio.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with T2D had a higher post 1\u00a0mg DST cortisol level and were more often diagnosed with hypertension, dyslipidemia and cardiovascular disease (CVD) compared to those without T2D. Compared to patients with non-functioning adrenal adenomas (NFAA) without T2D, MACS was strongly linked to increased mortality only in T2D (HR 2.51 [CI95% 1.41\u20134.48],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) but not in those without T2D, even after adjustment for age, sex, BMI, smoking, hypertension, dyslipidemia and CVD at baseline. The T2D cohort with MACS had higher HbA1c and a 3-fold elevation in CVD prevalence compared to those without hypercortisolism. They did not differ according to age, sex or other cardiometabolic risk parameters (dyslipidemia, hypertension, BMI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients with adrenal adenomas, MACS is related to increased CVD prevalence and is associated with mortality in patients with T2D. These findings highlight the need for confirmatory prospective studies incorporating larger sample sizes to further assess the importance of earlier identification and treatment of MACS in patients with T2D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-026-03360-4","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:07:41Z","timestamp":1790042861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mild autonomous cortisol secretion (MACS) is associated with increased mortality in patients with adrenal adenomas only in the presence of type 2 diabetes: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Luise","family":"Bellach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hofer-Zeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Slukov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea","family":"Kalender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naima","family":"Michler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Gard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Baumgartner-Parzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrig","family":"Marculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greisa","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kautzky-Willer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3959-1496","authenticated-orcid":false,"given":"Michael","family":"Leutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"1","key":"3360_CR1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"20","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023;189(1):G1\u2013G42. https:\/\/doi.org\/10.1093\/ejendo\/lvad066","journal-title":"Eur J Endocrinol Jul"},{"issue":"7","key":"3360_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","volume":"10","author":"T Deutschbein","year":"2022","unstructured":"Deutschbein T, Reimondo G, Di Dalmazi G, et al. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study. Lancet Diabetes Endocrinol Jul. 2022;10(7):499\u2013508. https:\/\/doi.org\/10.1016\/S2213-8587(22)00100-0.","journal-title":"Lancet Diabetes Endocrinol Jul"},{"key":"3360_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084340","author":"JA Higgs","year":"2022","unstructured":"Higgs JA, Quinn AP, Seely KD, et al Pathophysiological link between insulin resistance and adrenal incidentalomas. Int J Mol Sci Apr. 2022. https:\/\/doi.org\/10.3390\/ijms23084340.","journal-title":"Int J Mol Sci Apr"},{"issue":"1","key":"3360_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","volume":"43","author":"EB Geer","year":"2014","unstructured":"Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinol Metab Clin North Am Mar. 2014;43(1):75\u2013102. https:\/\/doi.org\/10.1016\/j.ecl.2013.10.005.","journal-title":"Endocrinol Metab Clin North Am Mar"},{"issue":"12","key":"3360_CR5","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2337\/dc24-2841","volume":"1","author":"JB Buse","year":"2025","unstructured":"Buse JB, Kahn SE, Aroda VR, et al. Prevalence of hypercortisolism in difficult-to-control type 2 diabetes. Diabetes Care Dec. 2025;1(12):2012\u201320. https:\/\/doi.org\/10.2337\/dc24-2841.","journal-title":"Diabetes Care Dec"},{"issue":"4","key":"3360_CR6","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","volume":"17","author":"ICM Pelsma","year":"2023","unstructured":"Pelsma ICM, Fassnacht M, Tsagarakis S, et al. Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis. Eur J Endocrinol Oct. 2023;17(4):S88\u2013101. https:\/\/doi.org\/10.1093\/ejendo\/lvad134.","journal-title":"Eur J Endocrinol Oct"},{"key":"3360_CR7","doi-asserted-by":"publisher","first-page":"156675","DOI":"10.1016\/j.metabol.2026.156675","volume":"182","author":"D Ferrari","year":"2026","unstructured":"Ferrari D, Bonaventura I, Tenuta M, et al. Rethinking hypercortisolism screening in obesity and diabetes: a systematic review and meta-analysis. Metabolism Sep. 2026;182:156675. https:\/\/doi.org\/10.1016\/j.metabol.2026.156675.","journal-title":"Metabolism Sep"},{"issue":"1","key":"3360_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-023-01836-1","volume":"2","author":"V Favero","year":"2023","unstructured":"Favero V, Aresta C, Parazzoli C, et al. The degree of cortisol secretion is associated with diabetes mellitus and hypertension in patients with nonfunctioning adrenal tumors. Cardiovasc Diabetol May. 2023;2(1):102. https:\/\/doi.org\/10.1186\/s12933-023-01836-1.","journal-title":"Cardiovasc Diabetol May"},{"issue":"3","key":"3360_CR9","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1080\/07853890802508934","volume":"41","author":"J Nijm","year":"2009","unstructured":"Nijm J, Jonasson L. Inflammation and cortisol response in coronary artery disease. Ann Med. 2009;41(3):224\u201333. https:\/\/doi.org\/10.1080\/07853890802508934.","journal-title":"Ann Med"},{"issue":"4","key":"3360_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1530\/EJE-11-1039","volume":"166","author":"G Di Dalmazi","year":"2012","unstructured":"Di Dalmazi G, Vicennati V, Rinaldi E, et al. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur J Endocrinol Apr. 2012;166(4):669\u201377. https:\/\/doi.org\/10.1530\/EJE-11-1039.","journal-title":"Eur J Endocrinol Apr"},{"issue":"1","key":"3360_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1530\/EJE-17-0047","volume":"177","author":"V Morelli","year":"2017","unstructured":"Morelli V, Palmieri S, Lania A, et al. Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks. Eur J Endocrinol Jul. 2017;177(1):73\u201383. https:\/\/doi.org\/10.1530\/EJE-17-0047.","journal-title":"Eur J Endocrinol Jul"},{"issue":"3","key":"3360_CR12","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1210\/jc.2013-3527","volume":"99","author":"V Morelli","year":"2014","unstructured":"Morelli V, Reimondo G, Giordano R, et al. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J Clin Endocrinol Metab Mar. 2014;99(3):827\u201334. https:\/\/doi.org\/10.1210\/jc.2013-3527.","journal-title":"J Clin Endocrinol Metab Mar"},{"issue":"2","key":"3360_CR13","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.beem.2021.101494","volume":"35","author":"C Aresta","year":"2021","unstructured":"Aresta C, Favero V, Morelli V, et al. Cardiovascular complications of mild autonomous cortisol secretion. Best Pract Res Clin Endocrinol Metab Mar. 2021;35(2):101494. https:\/\/doi.org\/10.1016\/j.beem.2021.101494.","journal-title":"Best Pract Res Clin Endocrinol Metab Mar"},{"issue":"5","key":"3360_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1530\/EJE-17-0986","volume":"178","author":"E Sbardella","year":"2018","unstructured":"Sbardella E, Minnetti M, D\u2019Aluisio D, et al. Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas. Eur J Endocrinol May. 2018;178(5):501\u201311. https:\/\/doi.org\/10.1530\/EJE-17-0986.","journal-title":"Eur J Endocrinol May"},{"issue":"3","key":"3360_CR15","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1210\/clinem\/dgad665","volume":"20","author":"AX Chen","year":"2024","unstructured":"Chen AX, Radhakutty A, Drake SM, Kiu A, Thompson CH, Burt MG. Cardiovascular risk markers in adults with adrenal incidentaloma and mild autonomous cortisol secretion. J Clin Endocrinol Metab Feb. 2024;20(3):e1020\u20138. https:\/\/doi.org\/10.1210\/clinem\/dgad665.","journal-title":"J Clin Endocrinol Metab Feb"},{"issue":"6","key":"3360_CR16","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1210\/clinem\/dgag095","volume":"19","author":"O Hamidi","year":"2026","unstructured":"Hamidi O, St-Jean M, Lacroix A, Bancos I. Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. J Clin Endocrinol Metab May. 2026;19(6):1513\u201327. https:\/\/doi.org\/10.1210\/clinem\/dgag095.","journal-title":"J Clin Endocrinol Metab May"},{"key":"3360_CR17","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee for D. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2026. Diabetes Care. Jan 1 2026;49(Supplement_1):S27\u2013S49. https:\/\/doi.org\/10.2337\/dc26-S002","DOI":"10.2337\/dc26-S002"},{"issue":"1","key":"3360_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mpr.329","volume":"20","author":"MJ Azur","year":"2011","unstructured":"Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res Mar. 2011;20(1):40\u20139. https:\/\/doi.org\/10.1002\/mpr.329.","journal-title":"Int J Methods Psychiatr Res Mar"},{"key":"3360_CR19","unstructured":"Austria S. Demographische Indikatoren und Tafeln. Accessed 25.06.2025, https:\/\/www.statistik.at\/ (Accessed 25.06.2025)."},{"issue":"5","key":"3360_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","volume":"2","author":"G Di Dalmazi","year":"2014","unstructured":"Di Dalmazi G, Vicennati V, Garelli S, et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol May. 2014;2(5):396\u2013405. https:\/\/doi.org\/10.1016\/S2213-8587(13)70211-0.","journal-title":"Lancet Diabetes Endocrinol May"},{"issue":"2","key":"3360_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","volume":"58","author":"J Patrova","year":"2017","unstructured":"Patrova J, Kjellman M, Wahrenberg H, Falhammar H. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center. Endocrine Nov. 2017;58(2):267\u201375. https:\/\/doi.org\/10.1007\/s12020-017-1400-8.","journal-title":"Endocrine Nov"},{"issue":"19","key":"3360_CR22","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"10","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med Nov. 2016;10(19):1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141.","journal-title":"N Engl J Med Nov"},{"issue":"10193","key":"3360_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","volume":"13","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet Jul. 2019;13(10193):121\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(19)31149-3.","journal-title":"Lancet Jul"},{"issue":"22","key":"3360_CR24","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"26","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. Nov 2015;26(22):2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1504720.","journal-title":"N Engl J Med"},{"issue":"7","key":"3360_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"17","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med Aug. 2017;17(7):644\u201357. https:\/\/doi.org\/10.1056\/NEJMoa1611925.","journal-title":"N Engl J Med Aug"},{"issue":"3","key":"3360_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7326\/M21-1737","volume":"175","author":"A Prete","year":"2022","unstructured":"Prete A, Subramanian A, Bancos I, et al Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study. Ann Intern Med. 2022;175(3):325\u201334. https:\/\/doi.org\/10.7326\/M21-1737.","journal-title":"Ann Intern Med"},{"issue":"3","key":"3360_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"18","author":"AD Pradhan","year":"2001","unstructured":"Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA Jul. 2001;18(3):327\u201334. https:\/\/doi.org\/10.1001\/jama.286.3.327.","journal-title":"JAMA Jul"},{"issue":"2","key":"3360_CR28","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1056\/NEJMc1705984","volume":"13","author":"JW Findling","year":"2017","unstructured":"Findling JW, Nieman L, Tabarin A. Diagnosis and differential diagnosis of cushing\u2019s syndrome. N Engl J Med Jul. 2017;13(2):e3. https:\/\/doi.org\/10.1056\/NEJMc1705984.","journal-title":"N Engl J Med Jul"},{"key":"3360_CR29","doi-asserted-by":"publisher","first-page":"1615735","DOI":"10.1155\/2016\/1615735","volume":"2016","author":"GT Russo","year":"2016","unstructured":"Russo GT, Giandalia A, Romeo EL, et al. Fracture risk in type 2 diabetes: current perspectives and gender differences. Int J Endocrinol. 2016;2016:1615735. https:\/\/doi.org\/10.1155\/2016\/1615735.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"3360_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S2213-8587(15)00283-1","volume":"4","author":"VV Shanbhogue","year":"2016","unstructured":"Shanbhogue VV, Mitchell DM, Rosen CJ, Bouxsein ML. Type 2 diabetes and the skeleton: new insights into sweet bones. Lancet Diabetes Endocrinol Feb. 2016;4(2):159\u201373. https:\/\/doi.org\/10.1016\/S2213-8587(15)00283-1.","journal-title":"Lancet Diabetes Endocrinol Feb"},{"issue":"3","key":"3360_CR31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.7570\/jomes.2017.26.3.227","volume":"26","author":"SH Yu","year":"2017","unstructured":"Yu SH, Kim YS, Lee KY. Resolution of metabolic disorders and overweight in a patient with ACTH-independent cushing\u2019s syndrome after unilateral adrenalectomy. J Obes Metab Syndr Sep. 2017;26(3):227\u201330. https:\/\/doi.org\/10.7570\/jomes.2017.26.3.227.","journal-title":"J Obes Metab Syndr Sep"},{"key":"3360_CR32","doi-asserted-by":"publisher","first-page":"898084","DOI":"10.3389\/fendo.2022.898084","volume":"13","author":"V Morelli","year":"2022","unstructured":"Morelli V, Frigerio S, Aresta C, et al. Adrenalectomy Improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion: results of a RCT. Front Endocrinol. 2022;13:898084. https:\/\/doi.org\/10.3389\/fendo.2022.898084.","journal-title":"Front Endocrinol"},{"issue":"6","key":"3360_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/SLA.0000000000006183","volume":"1","author":"JM Koh","year":"2024","unstructured":"Koh JM, Song K, Kwak MK, et al. Adrenalectomy improves body weight, glucose, and blood pressure control in patients with mild autonomous cortisol secretion: results of an randomized controlled trial by the co-work of adrenal research (COAR) study. Ann Surg Jun. 2024;1(6):945\u201352. https:\/\/doi.org\/10.1097\/SLA.0000000000006183.","journal-title":"Ann Surg Jun"},{"key":"3360_CR34","doi-asserted-by":"publisher","first-page":"103775","DOI":"10.1016\/j.eclinm.2026.103775","volume":"92","author":"H Niziolek","year":"2026","unstructured":"Niziolek H, Just I, Tosin A, et al. Metabolic effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a prospective proof-of-concept trial. EClinicalMedicine Feb. 2026;92:103775. https:\/\/doi.org\/10.1016\/j.eclinm.2026.103775.","journal-title":"EClinicalMedicine Feb"},{"key":"3360_CR35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgag228","author":"H Niziolek","year":"2026","unstructured":"Niziolek H, Just I, Baumgartner C, et al Cardiovascular effects of metyrapone treatment in patients with mild autonomous cortisol secretion: a secondary analysis. J Clin Endocrinol Metab Jun. 2026. https:\/\/doi.org\/10.1210\/clinem\/dgag228.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"3360_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/M16-0547","volume":"18","author":"D Lopez","year":"2016","unstructured":"Lopez D, Luque-Fernandez MA, Steele A, Adler GK, Turchin A, Vaidya A. Nonfunctional adrenal tumors and the risk for incident diabetes and cardiovascular outcomes: a cohort study. Ann Intern Med Oct. 2016;18(8):533\u201342. https:\/\/doi.org\/10.7326\/M16-0547.","journal-title":"Ann Intern Med"},{"issue":"2","key":"3360_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7326\/M18-3630","volume":"16","author":"YS Elhassan","year":"2019","unstructured":"Elhassan YS, Alahdab F, Prete A, et al. Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis. Ann Intern Med Jul. 2019;16(2):107\u201316. https:\/\/doi.org\/10.7326\/M18-3630.","journal-title":"Ann Intern Med Jul"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03360-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03360-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03360-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:03:34Z","timestamp":1790661814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03360-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3360"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03360-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"26 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki (ethical referral number of the Medical University of Vienna: 1731\/2020). Due to the retrospective design and full anonymization of routinely collected clinical data, the requirement for written informed consent was waived by the ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"294"}}